Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research

to
Auditorium I
Major session

Advances in drug treatment

to
Auditorium II
Oral presentation session

Innovative health approaches

to
Auditorium III
Oral presentation session

Innovative health approaches

to
Auditorium III
Oral presentation session

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Gambling: work-related, financial, and criminological issues

to
Room 5B
Oral presentation session

Gambling: work-related, financial, and criminological issues

to
Room 5B
Oral presentation session

Support for recovery

to
Room 1.07
Short communication session

Support for recovery

to
Room 1.07
Short communication session
Closed session

ECR Programme — Scientific writing

to
Room 1.10
Workshop

Evaluation of drug consumption rooms: guidance step by step

to
Room 1.15
Workshop

14:20

Alcohol use in the young

to
Auditorium II
Oral presentation session

Alcohol use in the young

to
Auditorium II
Oral presentation session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Tobacco, mental health and other substance use

to
Auditorium VII
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Substance use interventions in youth

to
Room 5A
Oral presentation session

Neurocognitive processes in behavioural addictions

to
Room 5B
Oral presentation session

Meetings the needs of women who use drugs or alcohol

to
Room 1.06
Short communication session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

Methods and measurement

to
Room 1.08
Short communication session

Methods and measurement

to
Room 1.08
Short communication session

The peer model: the critical role of ethics in efficacy

to
Room 1.15
Workshop

16:00

Alcohol use from brief intervention to harm reduction

to
Auditorium II
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Assessment of behavioural addictions

to
Room 5B
Oral presentation session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

LEGO® SERIOUS PLAY® Hands-On Workshop on Optimizing Workplace and Well-Being for Workers in Addiction Fields

to
Room 1.15
Workshop

17:50

Strengthening quality in substance use disorders treatment

to
Auditorium II
Oral presentation session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Understanding interrelationships: mental health and substance use

to
Auditorium VII
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Thu 24 Oct

10:00

Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.

to
Room 1.10
Workshop

11:50

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Challenges, threats, and opportunities in addiction publishing today

to
Room 1.05
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

14:20

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

European prevention curriculum: increasing the use of evidence-based prevention

to
Room 1.06
Short communication session

European prevention curriculum: increasing the use of evidence-based prevention

to
Room 1.06
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief

to
Room 1.15
Workshop

16:00

Alcohol epidemiology: social inequalities

to
Auditorium II
Oral presentation session

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Hepatitis C testing and treatment

to
Auditorium IV
Oral presentation session

Cannabis legalisation — models and impacts

to
Auditorium VI
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

Protective and risk factors in drug prevention

to
Room 5A
Oral presentation session

Protective and risk factors in drug prevention

to
Room 5A
Oral presentation session

Policy issues in gambling

to
Room 5B
Oral presentation session

Policy issues in gambling

to
Room 5B
Oral presentation session

From genes to brains

to
Room 1.06
Short communication session

From genes to brains

to
Room 1.06
Short communication session

Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain

to
Room 1.08
Oral presentation session

17:50

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Alcohol use among the elderly

to
Auditorium VI
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

New Research on Alcohol and Tobacco Policy

to
Room 5A
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

Behavioural addictions, prevention and theory

to
Room 1.05
Short communication session

Behavioural addictions, prevention and theory

to
Room 1.05
Short communication session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Internet, smartphones and social media use

to
Room 1.07
Short communication session

ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder

to
Room 1.08
Oral presentation session

A two-phased augmentation/intervention extension of Claremont’s media-based prevention education model

to
Room 1.10
Workshop

Fri 25 Oct

11:50

Gaming and social media use

to
Auditorium III
Oral presentation session

Gaming and social media use

to
Auditorium III
Oral presentation session

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Psychedelics 2

to
Auditorium VI
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Gaming and health

to
Room 1.06
Short communication session

Gaming and health

to
Room 1.06
Short communication session

14:20

Young people and drugs

to
Auditorium III
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session

Future of opioid markets in Europe: Foresight approaches

to
Room 1.10
Workshop